Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: New Cohen *FULL* Research Report on PTSC is OUT (1/5/09)
Reply New Message
Prev Message Back To Forum Threaded View Next Message

Our single point short-term and long-term price targets are $1.01 and $1.43,

respectively. I'l take it.

Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply